Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma-Reference-Cited by-同舟云学术

Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma

Published:2021-09-21 Issue:1 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Varlet Pascale¹,Bouffet Eric²,Casanova Michela³,Giangaspero Felice⁴⁵,Antonelli Manila⁴,Hargrave Darren⁶,Ladenstein Ruth⁷,Pearson Andy⁸⁹,Hawkins Cynthia²,König Fatima Barbara¹⁰,Rüschoff Josef¹⁰,Schmauch Christian¹⁰,Bühnemann Claudia¹¹,Garin‐Chesa Pilar¹²,Schweifer Norbert¹²,Uttenreuther‐Fischer Martina¹¹,Gibson Neil¹¹,Ittrich Carina¹¹,Krämer Nicole¹²,Solca Flavio¹³,Stolze Britta¹¹,Geoerger Birgit¹⁴

Affiliation:

1. GHU Psychiatrie et Neurosciences, site Sainte‐Anne service de Neuropathologie Paris France

2. The Hospital for Sick Children Toronto Ontario Canada

3. Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

4. Università Roma Sapienza Rome Italy

5. IRCCS Neuromed Pozzilli Italy

6. Great Ormond Street Hospital for Children NHS Foundation Trust London UK

7. Department of Paediatrics St. Anna Children's Cancer Research Institute, Medical University Vienna Austria

8. Paediatric Drug Development, Children and Young People's Unit Royal Marsden Hospital London UK

9. Division of Clinical Studies Institute of Cancer Research London UK

10. Targos Molecular Pathology GmbH Kassel Germany

11. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

12. Staburo GmbH, Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

13. Boehringer Ingelheim RCV GmbH & Co. KG Vienna Austria

14. Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015 Université Paris Saclay Villejuif France

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29316

Reference59 articles.

1. Implementation of mechanism of action biology-driven early drug development for children with cancer

2. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors;Bodey B;In Vivo,2005

3. Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer

4. ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology

5. Cancer statistics, 2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate;Journal of Controlled Release;2024-10

2. Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation;Molecular Therapy: Oncology;2024-06

3. Consensus guidelines for the management of intracranial ependymoma for low-and middle-income countries;J PAK MED ASSOC;2024

4. Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial;European Journal of Cancer;2023-07

5. HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma;Neuro-Oncology Advances;2023-01-01